Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bifidobacterium ruminatum co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [4], [5] |
Testosterone cypionate |
Click to Show/Hide the Detail |
Drug ID |
DR1564
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [7], [4] |
Bacteria: Bacteroidetes |
Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Alistipes indistinctus co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
NAB-365 |
Click to Show/Hide the Detail |
Drug ID |
DR0338
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides caccae co-metabolize the drug NAB-365, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides caccae co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides coprophilus co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [10] |
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides dorei co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides dorei co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides eggerthii co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides fragilis co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides fragilis co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides ovatus co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides ovatus co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides sartorii co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides sartorii co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides stercoris co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides stercoris co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides thetaiotaomicron co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides thetaiotaomicron co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides vulgatus co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides vulgatus co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides xylanisolvens co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacteroides xylanisolvens co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Odoribacter splanchnicus co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Odoribacter splanchnicus co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Parabacteroides distasonis co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Prevotella copri co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Firmicutes |
Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacillus megaterium co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [12] |
Amodiaquine |
Click to Show/Hide the Detail |
Drug ID |
DR0102
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacillus megaterium co-metabolize the drug Amodiaquine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [12] |
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [14] |
Progesterone |
Click to Show/Hide the Detail |
Drug ID |
DR1346
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacillus megaterium co-metabolize the drug Progesterone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [15] |
Testosterone cypionate |
Click to Show/Hide the Detail |
Drug ID |
DR1564
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [15], [16] |
Bacillus subtilis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riboflavin |
Click to Show/Hide the Detail |
Drug ID |
DR1416
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Bacillus subtilis co-metabolize the drug Riboflavin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [18] |
Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Blautia hansenii co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Clostridioides difficile co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [19] |
Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Procarbazine |
Click to Show/Hide the Detail |
Drug ID |
DR1344
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Clostridium botulinum co-metabolize the drug Procarbazine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Clostridium botulinum co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Clostridium sporogenes co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Enterococcus faecalis co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [19] |
Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Erysipelatoclostridium ramosum co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [10] |
Menadione |
Click to Show/Hide the Detail |
Drug ID |
DR1022
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Faecalibacterium prausnitzii co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [21] |
Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Lactobacillus reuteri co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [10] |
Lactobacillus sakei (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Erythromycin stearate |
Click to Show/Hide the Detail |
Drug ID |
DR0614
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Lactobacillus sakei co-metabolize the drug Erythromycin stearate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [23], [24] |
Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Roseburia intestinalis co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [10] |
Staphylococcus aureus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riboflavin |
Click to Show/Hide the Detail |
Drug ID |
DR1416
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Staphylococcus aureus co-metabolize the drug Riboflavin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [25] |
Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Subdoligranulum variabile co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Proteobacteria |
Citrobacter freundii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Citrobacter freundii co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [19] |
Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Escherichia coli co-metabolize the drug Acetaminophen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [19] |
Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Nicotine |
Click to Show/Hide the Detail |
Drug ID |
DR1148
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[26], [27] |
Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Menadione |
Click to Show/Hide the Detail |
Drug ID |
DR1022
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Salmonella enterica co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [28], [29] |
Salmonella typhimurium (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riboflavin |
Click to Show/Hide the Detail |
Drug ID |
DR1416
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Salmonella typhimurium co-metabolize the drug Riboflavin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [28], [30] |
Bacteria: Verrucomicrobia |
Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riluzole |
Click to Show/Hide the Detail |
Drug ID |
DR1425
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) and Akkermansia muciniphila co-metabolize the drug Riluzole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Fungi: Ascomycota |
Saccharomyces cerevisiae (ascomycota) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Acetaminophen |
Click to Show/Hide the Detail |
Drug ID |
DR0037
Drug Info
|
Interaction Mechanism |
Human Cytochrome P450 1A1 (CYP1A1) metabolizes the drug Acetaminophen, and Saccharomyces cerevisiae further metabolizes its metabolite (1-Phenyl-1,2-propanedione), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[11], [19] |
|
|
|
|
|
|